Technetium -99m is an isomer of technetium 99, which is used in nuclear medicine and the precursor for technetium-99 is molybdenum-99, a radioactive nuclei generally produced in reactors. Technetium-99m is used as a radioactive tracer and can be detected in the body by equipment such as gamma cameras, as Tc-99m emits gamma rays. Technetium-99m, in the form of sodium pertechnetate (Na99mTcO4), is easily obtained from a 99Mo99mTc generator. Sodium Pertechnetate Tc 99m Injection is used in adults as an agent for thyroid imaging, salivary gland imaging, urinary bladder imaging (direct isotopic cystography) for the detection of vesico-ureteral reflux, coronary artery disease, and nasolacrimal drainage system imaging.   Technetium-99m (Tc-99m) is frequently utilized in nuclear medicine imaging techniques. Due to its short half-life, it may be administered to patients safely while lowering radiation exposure. In the Middle East and other parts of the world, tc-99m is often utilized for a variety of diagnostic procedures, including cardiac perfusion imaging, bone scans, lung scans, and others.

Market Dynamics

High prevalence of congenital heart disease among individuals with Down syndrome is expected to propel the growth of the MEA technetium-99m market over the forecast period. For instance, in November 2022, National Center for Biotechnology Information published data according to which during the year 2016 to 2020 the prevalence of congenital heart disease in subjects with Down Syndrome in the Kingdom of Saudi Arabia and showed a prevalence of 66.1% (95% CI: 57.2% to 74.5%). Down syndrome is a key factor in morbidity and early death in these individuals with congenital heart diseases.

Key features of the study:

• This report provides an in-depth analysis of the MEA Technetium-99m Market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the MEA Technetium-99m Market  based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include GE Healthcare, IBA, Sumitomo Corporation, BWX Technologies, Inc., Advanced Cyclotron Systems, Inc., Navidea Biopharmaceuticals, Inc., BEST Cyclotron Systems Inc., NorthStar Medical Radioisotopes, and Siemens Healthineers.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The MEA Technetium-99m Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts1
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the MEA Technetium-99m Market

Detailed Segmentation:

• MEA Technetium 99m Market, By Isotopic Application:
  • Gamma Camera
  • SPECT
• MEA Technetium 99m Market, By End User:
  • Hospitals
  • Diagnostic Center
• MEA Technetium 99m Market, By Country:
  • Saudi Arabia
  • Algeria
  •  Bahrain
  • Cyprus
  • Egypt
  • Iran
  • Iraq
  • Israel
  • Jordan
  • Kuwait
  • Lebanon
  • Libya
  • Morocco
  • Mauritania 
  • Oman
  • Palestine
  • Qatar
  •  Syria
  • Tunisia
  • Turkey
  • Yemen
• Company Profiles
  • GE Healthcare 
  • IBA
  • Sumitomo Corporation
  • BWX Technologies, Inc.
  • Advanced Cyclotron Systems, Inc.
  • Navidea Biopharmaceuticals, Inc.
  • BEST Cyclotron Systems Inc.
  • NorthStar Medical Radioisotopes
  • Siemens Healthineers.
  • Other Prominent Players